Samar A. Jasser

9.0k total citations · 1 hit paper
53 papers, 5.6k citations indexed

About

Samar A. Jasser is a scholar working on Molecular Biology, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Samar A. Jasser has authored 53 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 22 papers in Oncology and 13 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Samar A. Jasser's work include Thyroid Cancer Diagnosis and Treatment (12 papers), PI3K/AKT/mTOR signaling in cancer (10 papers) and Cancer-related Molecular Pathways (8 papers). Samar A. Jasser is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (12 papers), PI3K/AKT/mTOR signaling in cancer (10 papers) and Cancer-related Molecular Pathways (8 papers). Samar A. Jasser collaborates with scholars based in United States, Australia and China. Samar A. Jasser's co-authors include Jeffrey N. Myers, Peter A. Steck, Mark A. Pershouse, W.K. Alfred Yung, Huai Lin, Lauren A. Langford, Azra H. Ligon, Cheryl A. Frye, Rong Hu and Thomas Hattier and has published in prestigious journals such as Nature Genetics, Cancer and Cancer Research.

In The Last Decade

Samar A. Jasser

53 papers receiving 5.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers

1997 2.3k citations Peter A. Steck, Mark A. Pershouse et al. Nature Genetics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Samar A. Jasser United States	33	3.0k	1.4k	769	566	524	53	5.6k
Nigel Whittle Austria	34	4.2k 1.4×	2.3k 1.6×	664 0.9×	154 0.3×	545 1.0×	51	8.3k
Steven G. Kernie United States	33	2.5k 0.8×	866 0.6×	1.0k 1.3×	313 0.6×	372 0.7×	79	6.8k
Lodewijk A. Sandkuijl Netherlands	44	3.9k 1.3×	529 0.4×	414 0.5×	304 0.5×	174 0.3×	94	7.7k
Rudolf Kirchmair Austria	43	2.7k 0.9×	724 0.5×	484 0.6×	240 0.4×	438 0.8×	114	6.1k
Robert S. Sparkes United States	47	4.0k 1.3×	1.3k 0.9×	577 0.8×	101 0.2×	369 0.7×	205	9.8k
Luís Hernández Spain	40	1.7k 0.5×	1.5k 1.0×	507 0.7×	182 0.3×	431 0.8×	95	4.2k
Peter J. Fuller Australia	53	3.2k 1.1×	740 0.5×	480 0.6×	226 0.4×	1.0k 1.9×	313	9.6k
Dick Lindhout Netherlands	45	4.1k 1.4×	1.1k 0.8×	399 0.5×	334 0.6×	703 1.3×	174	10.8k
Jane M. Moseley Australia	46	4.3k 1.4×	3.8k 2.6×	475 0.6×	120 0.2×	554 1.1×	105	7.7k
Claudine Junien France	57	5.6k 1.8×	604 0.4×	954 1.2×	146 0.3×	1.1k 2.1×	241	10.9k

Countries citing papers authored by Samar A. Jasser

Since Specialization

Citations

This map shows the geographic impact of Samar A. Jasser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samar A. Jasser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samar A. Jasser more than expected).

Fields of papers citing papers by Samar A. Jasser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samar A. Jasser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samar A. Jasser. The network helps show where Samar A. Jasser may publish in the future.

Co-authorship network of co-authors of Samar A. Jasser

This figure shows the co-authorship network connecting the top 25 collaborators of Samar A. Jasser. A scholar is included among the top collaborators of Samar A. Jasser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samar A. Jasser. Samar A. Jasser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Sandulache, Vlad C., Chieko Michikawa, Frederico O. Gleber‐Netto, et al.. (2018). High-Risk TP53 Mutations Are Associated with Extranodal Extension in Oral Cavity Squamous Cell Carcinoma. Clinical Cancer Research. 24(7). 1727–1733. 40 indexed citations

2.

Gleber‐Netto, Frederico O., Mei Zhao, Sanchit Trivedi, et al.. (2017). Distinct pattern of TP53 mutations in human immunodeficiency virus–related head and neck squamous cell carcinoma. Cancer. 124(1). 84–94. 18 indexed citations

3.

Pickering, Curtis R., Jiexin Zhang, David M. Neskey, et al.. (2014). Squamous Cell Carcinoma of the Oral Tongue in Young Non-Smokers Is Genomically Similar to Tumors in Older Smokers. Clinical Cancer Research. 20(14). 3842–3848. 118 indexed citations

4.

Zhao, Mei, Daisuke Sano, Curtis R. Pickering, et al.. (2011). Assembly and Initial Characterization of a Panel of 85 Genomically Validated Cell Lines from Diverse Head and Neck Tumor Sites. Clinical Cancer Research. 17(23). 7248–7264. 224 indexed citations

5.

Chen, Yunyun, Daisuke Sano, Mitchell J. Frederick, et al.. (2011). Targeted Therapy of VEGFR2 and EGFR Significantly Inhibits Growth of Anaplastic Thyroid Cancer in an Orthotopic Murine Model. Clinical Cancer Research. 17(8). 2281–2291. 68 indexed citations

6.

Rosenzweig, Steven A, Jeffrey M. Greeson, Diane Reibel, et al.. (2009). Mindfulness-based stress reduction for chronic pain conditions: Variation in treatment outcomes and role of home meditation practice. Journal of Psychosomatic Research. 68(1). 29–36. 355 indexed citations

7.

Kim, Seungwon, et al.. (2007). Concurrent Cetuximab and Bevacizumab Therapy in a Murine Orthotopic Model of Anaplastic Thyroid Carcinoma. The Laryngoscope. 117(4). 674–679. 39 indexed citations

8.

Melancon, Marites P., Yuetang Wang, Xiaoxia Wen, et al.. (2007). Development of a Macromolecular Dual-Modality MR-Optical Imaging for Sentinel Lymph Node Mapping. Investigative Radiology. 42(8). 569–578. 40 indexed citations

9.

Younes, Maher N., Orhan G. Yigitbasi, Yasemin D. Yazici, et al.. (2007). Effects of the Integrin-Linked Kinase Inhibitor QLT0267 on Squamous Cell Carcinoma of the Head and Neck. Archives of Otolaryngology - Head and Neck Surgery. 133(1). 15–15. 32 indexed citations

10.

Blask, David E., George C. Brainard, Robert T. Dauchy, et al.. (2005). Melatonin-Depleted Blood from Premenopausal Women Exposed to Light at Night Stimulates Growth of Human Breast Cancer Xenografts in Nude Rats. Cancer Research. 65(23). 11174–11184. 344 indexed citations

11.

Kim, Seung Won, Yasemin D. Yazici, Samar A. Jasser, et al.. (2005). Growth inhibition of orthotopic anaplastic thyroid carcinoma xenografts in nude mice by PTK787/ZK222584 and CPT‐11. Head & Neck. 28(5). 389–399. 13 indexed citations

12.

Yazici, Yasemin D., et al.. (2005). Antivascular Therapy of Oral Tongue Squamous Cell Carcinoma with PTK787. The Laryngoscope. 115(12). 2249–2255. 16 indexed citations

13.

Schiff, Bradley A., Samar A. Jasser, Maher N. Younes, et al.. (2004). Epidermal Growth Factor Receptor (EGFR) Is Overexpressed in Anaplastic Thyroid Cancer, and the EGFR Inhibitor Gefitinib Inhibits the Growth of Anaplastic Thyroid Cancer. Clinical Cancer Research. 10(24). 8594–8602. 142 indexed citations

14.

Myers, Jeffrey N., F. Christopher Holsinger, B. Nebiyou Bekele, et al.. (2002). Targeted Molecular Therapy for Oral Cancer With Epidermal Growth Factor Receptor Blockade. Archives of Otolaryngology - Head and Neck Surgery. 128(8). 875–875. 22 indexed citations

15.

Cohen, Mitchell J., et al.. (2002). Ethical Perspectives: Opioid Treatment of Chronic Pain in the Context of Addiction. Clinical Journal of Pain. 18(Supplement). S99–S107. 30 indexed citations

16.

Koul, Dimpy, Samar A. Jasser, Yiling Lu, et al.. (2002). Motif analysis of the tumor suppressor gene MMAC/PTEN identifies tyrosines critical for tumor suppression and lipid phosphatase activity. Oncogene. 21(15). 2357–2364. 51 indexed citations

17.

Koul, Dimpy, Samar A. Jasser, Yiling Lu, et al.. (2002). Motif analysis of the tumor suppressor gene MMAC/PTEN identifies tyrosines critical for tumor suppression and lipid phosphatase activity. Oncogene. 21(15). 2357–2364. 51 indexed citations

18.

Steck, Peter A., Huai Lin, Lauren A. Langford, et al.. (1999). Functional and molecular analyses of 10q deletions in human gliomas. Genes Chromosomes and Cancer. 24(2). 135–143. 46 indexed citations

19.

Steck, Peter A., Mark A. Pershouse, Samar A. Jasser, et al.. (1997). Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nature Genetics. 15(4). 356–362. 2266 indexed citations breakdown →

20.

Ligon, Azra H., et al.. (1997). Identification of a novel gene product, RIG, that is down-regulated in human glioblastoma. Oncogene. 14(9). 1075–1081. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact